FANGZHOU JIANKE

Fangzhou Inc. surged 19.7% today, driven by market recognition of its AI-powered chronic disease management platform and recent profitability milestone. The stock hit an afternoon high of HK$0.840 and closed at HK$0.790, far above a morning low of HK$0.660, yet the YTD decline stands at 64.6%, with the current price 85% below its 52-week high of HK$5.26 and below the 20-day MA of HK$0.851. Q4 revenue jumped 53.5% YoY to HK$1.13 billion, while net loss narrowed 98% to just HK$0.36 million, nearing breakeven, though net profit margin remained negative at -0.03%. However, the company recently raised approximately HK$144 million through a share placement for AI platform expansion, which may cap further upside amid dilution concerns.